Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1

被引:332
|
作者
Chen, HK
Fernandez-Funez, P
Acevedo, SF
Lam, YC
Kaytor, MD
Fernandez, MH
Aitken, A
Skoulakis, EMC
Orr, HT
Botas, J
Zoghbi, HY
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA
[4] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA
[5] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
[6] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
[7] Texas A&M Univ, Genet Program, College Stn, TX 77843 USA
[8] CSRC A Fleming, Inst Mol Biol & Genet, Vari 16672, Greece
[9] Univ Edinburgh, Div Biomed & Clin Lab Sci, Edinburgh EH8 9XD, Midlothian, Scotland
关键词
D O I
10.1016/S0092-8674(03)00349-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spinocerebellar ataxia type 1 (SCA1) is one of several neurological disorders caused by a CAG repeat expansion. In SCA1, this expansion produces an abnormally long polyglutamine tract in the protein ataxin-1. Mutant polyglutamine proteins accumulate in neurons, inducing neurodegeneration, but the mechanism underlying this accumulation has been unclear. We have discovered that the 14-3-3 protein, a multifunctional regulatory molecule, mediates the neurotoxicity of ataxin-1 by binding to and stabilizing ataxin-1, thereby slowing its normal degradation. The association of ataxin-1 with 14-3-3 is regulated by Akt phosphorylation, and in a Drosophila model of SCA1, both 14-3-3 and Akt modulate neurodegeneration. Our finding that phosphatidylinositol 3-kinase/Akt signaling and 14-3-3 cooperate to modulate the neurotoxicity of ataxin-1 provides insight into SCA1 pathogenesis and identifies potential targets for therapeutic intervention.
引用
收藏
页码:457 / 468
页数:12
相关论文
共 50 条
  • [31] Interaction of phosphorylated tryptophan hydroxylase with 14-3-3 proteins
    Banik, U
    Wang, GA
    Wagner, PD
    Kaufman, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) : 26219 - 26225
  • [32] Metabolic Evidence for Cerebral Neurodegeneration in Spinocerebellar Ataxia Type 1
    Doss, Sarah
    Brandt, Alexander U.
    Oberwahrenbrock, Timm
    Endres, Matthias
    Paul, Friedemann
    Rinnenthal, Jan Leo
    CEREBELLUM, 2014, 13 (02): : 199 - 206
  • [33] Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1
    Shuvaev, Anton N.
    Belozor, Olga S.
    Mozhei, Oleg, I
    Shuvaev, Andrey N.
    Fritsler, Yana, V
    Khilazheva, Elena D.
    Mosyagina, Angelina, I
    Hirai, Hirokazu
    Teschemacher, Anja G.
    Kasparov, Sergey
    CELLS, 2022, 11 (14)
  • [34] Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3
    Johnson, Sean L.
    Blount, Jessica R.
    Libohova, Kozeta
    Ranxhi, Bedri
    Paulson, Henry L.
    Tsou, Wei-Ling
    Todi, Sokol V.
    NEUROBIOLOGY OF DISEASE, 2019, 132
  • [35] Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
    Matos, Carlos A.
    Nobrega, Clevio
    Louros, Susana R.
    Almeida, Bruno
    Ferreiro, Elisabete
    Valero, Jorge
    de Almeida, Luis Pereira
    Macedo-Ribeiro, Sandra
    Carvalho, Ana Luisa
    JOURNAL OF CELL BIOLOGY, 2016, 212 (04): : 465 - 480
  • [36] Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
    Grosch, Anne Sophie
    Rinnenthal, Jan Leo
    Roennefarth, Maria
    Lux, Silke
    Scheel, Michael
    Endres, Matthias
    Brandt, Alexander U.
    Paul, Friedemann
    Schmitz-Huebsch, Tanja
    Minnerop, Martina
    Doss, Sarah
    CEREBELLUM, 2021, 20 (02): : 169 - 178
  • [37] Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
    Anne Sophie Grosch
    Jan Leo Rinnenthal
    Maria Rönnefarth
    Silke Lux
    Michael Scheel
    Matthias Endres
    Alexander U. Brandt
    Friedemann Paul
    Tanja Schmitz-Hübsch
    Martina Minnerop
    Sarah Doss
    The Cerebellum, 2021, 20 : 169 - 178
  • [38] Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy
    Keiser, Megan S.
    Kordower, Jeffrey H.
    Gonzalez-Alegre, Pedro
    Davidson, Beverly L.
    BRAIN, 2015, 138 : 3555 - 3566
  • [39] LANP mediates neuritic pathology in Spinocerebellar ataxia type 1
    Cvetanovic, Marija
    Kular, Rupinder K.
    Opal, Puneet
    NEUROBIOLOGY OF DISEASE, 2012, 48 (03) : 526 - 532
  • [40] 14-3-3 binding to Ataxin-1 (ATXN1) regulates its dephosphorylation at Ser-776 and transport to the nucleus (vol 286, pg 34606, 2011)
    Lai, Shaojuan
    O'Callaghan, Brennon
    Zoghbi, Huda Y.
    Orr, Harry T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (09) : 6590 - 6590